Central role of interferon-beta in thymic events leading to myasthenia gravis
- 3 January 2014
- journal article
- research article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 52, 44-52
- https://doi.org/10.1016/j.jaut.2013.12.016
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Emerging therapies for systemic lupus erythematosus — Focus on targeting interferon-alphaClinical Immunology, 2012
- Induction and function of type I and III interferon in response to viral infectionCurrent Opinion in Virology, 2011
- The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptorNature Immunology, 2011
- The Type I Interferon Signaling Pathway Is a Target for Glucocorticoid InhibitionMolecular and Cellular Biology, 2010
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In VivoPLoS Pathogens, 2008
- Proliferative arrest and rapid turnover of thymic epithelial cells expressing AireThe Journal of Experimental Medicine, 2007
- Myasthenia Gravis Thymus: Complement Vulnerability of Epithelial and Myoid Cells, Complement Attack on Them, and Correlations with Autoantibody StatusThe American Journal of Pathology, 2007
- Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody productionSeminars in Immunology, 2006
- The Thymus Is a Common Target Organ in Infectious DiseasesPLoS Pathogens, 2006
- Cells Previously Desensitized to Type 1 Interferons Display Different Mechanisms of Activation of Stat-dependent Gene Expression from Naïve CellsOnline Journal of Public Health Informatics, 2004